Naprossene E Esomeprazolo Abdi (Esomeprazole, Naproxen)

Esomeprazole, the active ingredient in Naprossene E, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to manage gastro‑oesophageal reflux disease and related acid‑related disorders in adults. Naproxen, also present in the combination, is a non‑steroidal anti‑inflammatory drug that provides analgesic and anti‑inflammatory effects.

GNH USA supplies Naprossene E as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naprossene E combines a proton pump inhibitor and an NSAID, addressing both acid‑related conditions and pain‑inflammation pathways. - GERD: Reduces gastric acid to relieve heartburn and esophageal irritation. - Peptic ulcer disease: Promotes ulcer healing by lowering acid exposure. - Osteoarthritis: Alleviates joint pain and inflammation. - Rheumatoid arthritis: Decreases inflammatory pain and swelling. - Acute musculoskeletal pain: Provides rapid analgesia and anti‑inflammatory action.

The combination may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Dyspepsia: upper abdominal discomfort. - Diarrhea: loose stools. - Nausea: feeling of sickness. - Abdominal pain: cramping or tenderness. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Gastrointestinal bleeding: black stools or vomiting blood. - Peptic ulcer perforation: sudden severe abdominal pain. - Renal impairment: reduced urine output or swelling. - Hepatotoxicity: jaundice or elevated liver enzymes. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Cardiovascular events: chest pain or shortness of breath.

Patients should be aware of specific safety considerations before using this combination. - Assess renal function: monitor creatinine in patients with kidney disease. - Evaluate hepatic status: avoid use in severe liver impairment. - Review cardiovascular risk: NSAIDs may increase blood pressure and thrombotic events. - Avoid concurrent anticoagulants: higher risk of gastrointestinal bleeding. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Naprossene E may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Warfarin: increased bleeding risk. - Methotrexate: elevated toxicity levels. - Lithium: heightened serum concentrations. - Cyclosporine: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - SSRIs (e.g., sertraline): additive bleeding risk. - Diuretics (e.g., furosemide): potential reduction in renal clearance. - ACE inhibitors: possible decrease in antihypertensive effect. - Antacids containing aluminum or magnesium: may affect absorption of esomeprazole.